Pasithea Therapeutics Corp. Common Stock KTTA
$0.48
+0.52%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 10-Q | QUARTERLY REPORT | 2026-08-14 | View → |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 2026-08-07 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-22 | View → |
| 10-Q | QUARTERLY REPORT | 2026-05-15 | View → |
| 4 | Insider transaction | 2026-05-05 | View → |
| 4 | Insider transaction | 2026-05-05 | View → |
| 4 | Insider transaction | 2026-05-05 | View → |
| 4 | Insider transaction | 2026-05-05 | View → |
| 4 | Insider transaction | 2026-05-05 | View → |
| 4 | Insider transaction | 2026-05-05 | View → |
| 4 | Insider transaction | 2026-05-05 | View → |
| 8-K | CURRENT REPORT | 2026-05-04 | View → |
| 10-K | ANNUAL REPORT | 2026-03-30 | View → |
| 8-K | CURRENT REPORT | 2026-02-20 | View → |
| 8-K | CURRENT REPORT | 2026-01-28 | View → |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 2025-12-29 | View → |
| 8-K | CURRENT REPORT | 2025-12-15 | View → |
| 8-K | CURRENT REPORT | 2025-12-02 | View → |
| 4 | Insider transaction | 2025-12-01 | View → |
| 4 | Insider transaction | 2025-12-01 | View → |
| 4 | Insider transaction | 2025-12-01 | View → |
| 4 | Insider transaction | 2025-12-01 | View → |
| 4 | Insider transaction | 2025-12-01 | View → |
| 8-K | CURRENT REPORT | 2025-11-25 | View → |
| S-1 | REGISTRATION STATEMENT | 2025-11-18 | View → |
| 10-Q | QUARTERLY REPORT | 2025-11-13 | View → |
| 8-K | CURRENT REPORT | 2025-11-04 | View → |
| 4 | Insider transaction | 2025-10-27 | View → |
| 4 | Insider transaction | 2025-10-27 | View → |
| 4 | Insider transaction | 2025-10-27 | View → |
| 4 | Insider transaction | 2025-10-27 | View → |
| 4 | Insider transaction | 2025-10-27 | View → |
| 4 | Insider transaction | 2025-10-27 | View → |
| 8-K | CURRENT REPORT | 2025-10-27 | View → |
| 8-K | CURRENT REPORT | 2025-09-16 | View → |
| 8-K | CURRENT REPORT | 2025-09-03 | View → |
| 10-Q | QUARTERLY REPORT | 2025-08-14 | View → |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 2025-07-24 | View → |
| 8-K | CURRENT REPORT | 2025-07-11 | View → |
| 8-K | CURRENT REPORT | 2025-06-27 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $0.48
- Market Cap
- $16.06 million
- 52-Week Range
- $0.28 – $2.06
- Average Volume
- 299K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.